
News & Trends - MedTech & Diagnostics

Surgeons warn patient care at risk as government drags its feet
As industrial action ripples through NSW Health and doctors resign in droves from ACT hospitals, the Royal Australasian College of […]
MoreNews & Trends - MedTech & Diagnostics

Australia charts global first in prostate cancer diagnosis
Australia is set to become the first country in the world to introduce national clinical guidelines for the early detection […]
MoreNews & Trends - MedTech & Diagnostics

Australia set to launch first atrial fibrillation registry
A new national clinical quality registry aimed at improving patient outcomes and addressing disparities in access to atrial fibrillation (AF) […]
MoreNews & Trends - MedTech & Diagnostics

Changing minds: Should insurers step up in mental health or stick to their lane?
Australia’s mental health system is at a crossroads. Vision 2030 sets out an ambitious promise: universal access to affordable, evidence-based […]
MoreNews & Trends - MedTech & Diagnostics

Healthscope must not be let off the hook with taxpayers footing the bill
The future of Northern Beaches Hospital hangs in the balance, as the New South Wales Government weighs a potential buyback […]
MoreNews & Trends - MedTech & Diagnostics

‘Shut up and pay us’: NSW public hospital doctors escalate strike, the first in 25 years
Thousands of public hospital doctors in New South Wales walk off the job for a third consecutive day today, intensifying […]
MoreNews & Trends - MedTech & Diagnostics

Melbourne hospital first to introduce Varian’s cutting edge radiation therapy technology
Cancer patients undergoing radiation therapy are now benefiting from dramatically shorter treatment times, thanks to the introduction of advanced medical […]
MoreNews & Trends - MedTech & Diagnostics

New robotic launch in lung cancer diagnosis ahead of national screening rollout
Australia has officially welcomed a next-generation bronchoscopy system, coinciding with the launch of the National Lung Cancer Screening program in […]
MoreNews & Trends - MedTech & Diagnostics

‘You can’t pretend to care about women’s health while slashing essential pathology tests,’ experts warn
The Federal Government is forging ahead with a plan to axe $356 million from Medicare rebates for pathology tests, triggering […]
MoreNews & Trends - MedTech & Diagnostics

Minns Labor Government fails to deliver the healthcare people in NSW deserve
Starting today, for the first time in more than 25 years, thousands of doctors across public hospitals in New South […]
MoreRecent Posts in Pharma, MedTech & Biotech
Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
April 17, 2025
in News & Trends - MedTech & Diagnostics
Oncologists pioneer liquid biopsy-guided treatment in lung cancer
April 17, 2025
in News & Trends - Pharmaceuticals
The high cost of record low research funding
April 17, 2025
in Medical and Science
UCB secures dermatology indication with first dual IL-17A/F inhibitor
April 17, 2025
in News & Trends - Pharmaceuticals
New Medicines Australia policy leader critical to HTA reforms
April 15, 2025
in Leadership & Management
How Australia’s employee engagement measures up
April 15, 2025
in Human Resources
PBAC issues criticism of pharma industry’s reimbursement submissions
April 15, 2025
in News & Trends - Pharmaceuticals
Surgeons warn patient care at risk as government drags its feet
April 15, 2025
in News & Trends - MedTech & Diagnostics
Follow Us
Partner with us
News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms
Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]
MoreNews & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer
Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]
MoreMedical and Science

The high cost of record low research funding
Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]
MoreNews & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor
UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]
More